Viernes, 04 Diciembre, 2020

The Achillion Pharmaceuticals, Inc. (ACHN) Set to Announce Earnings on Thursday

Manuel Armenta | 07 Marcha, 2017, 10:05

They issued a "buy" rating and a $10.00 target price for the company. This rating was issued on 2/10/17. It has ranged in price between $6.3242-$6.6 after having started the session at $6.43 as compared to the previous trading day's close of $6.46.

Price Target is basically a projection of future price of a company's stock by the expert analysis of investment analysts or investment firms. They now have a Dollars 7.5 price target on the stock. (NASDAQ:SPPI) to Outperform by settling a price target of $9 on 4/02/15. They now have a Dollars 6.75 price target on the stock.

09/15/2016 - Spectrum Pharmaceuticals, Inc. had its "buy" rating reiterated by analysts at H.C. Wainwright.

Given that SPPI has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings.

Jefferies began new coverage on Spectrum Pharmaceuticals, Inc. giving the company a "buy" rating. Achillion Pharmaceuticals has a 12-month low of $3.75 and a 12-month high of $10.06.

Several sell side analysts reviewed their recommendations on Spectrum Pharmaceuticals, Inc.

A number of equities analysts have weighed in on the stock.

Want the latest recommendations from Zacks Investment Research? Strong Sell. Investors might also notice that two months ago the Buy recommendations (0) were less than Sell recommendations (0).

In the last Quarter, Spectrum Pharmaceuticals, Inc.

NASDAQ:SPPI) was down -0.77% (-$0.05) to $6.41 and showed a volume of 0.97 mln shares.

The analysts offering 12 month price targets for Spectrum Pharmaceuticals, Inc. have a median target of $10, with a high estimate of $10 and a low estimate of $7.5. (NASDAQ:SPPI) could bring EPS of $-0.32/share. The difference between Actual EPS and Estimated EPS was 0.1 Percent.

04/02/2015 - Spectrum Pharmaceuticals, Inc. had its "outperform" rating reiterated by analysts at FBR Capital Markets. The stock touched its high share price of $7.74 on April 25, 2016 and the stock also touched its Lowest price in the last 52-weeks of trading on Nov 3, 2016 as $3.21.

The technical rating goes from one, the weakest upside technical, to five, the highest upside technical and focuses on the real-time stock price relative to various moving averages as well as moving averages relative to each other.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is now showing its ROA (Return on Assets) of -13%. Click to get this free reportSpectrum Pharmaceuticals, Inc.

The stock now has its Annual Dividend of $0 and an annual Dividend Yield of 0 Percent.

In fact, the Most Accurate Estimate for the current quarter is now at a loss of 22 cents per share for SPPI, compared to a broader Zacks Consensus Estimate of a loss of 26 cents per share. The stock is showing its Operating Margin of -29.3 percent.